Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.76 +0.03 (+1.73%)
At close: Oct 21, 2026 · 4:00 PM EDT

Processa Pharmaceuticals (PCSA) Long-Term Deferred Tax (2014 - 2016)

Updated

Processa Pharmaceuticals (PCSA) posted Long-Term Deferred Tax of -$135.00 for Q4 2016, compared with -$16,533 a year earlier.

Analysis

Processa Pharmaceuticals (PCSA) Long-Term Deferred Tax (2014 - 2016) Analysis & Trends

  • In prior years, Processa Pharmaceuticals' Long-Term Deferred Tax was -$16,533 in FY2015 and $155,232 in FY2014.
  • The Q4 2016 figure stands as the highest quarterly Long-Term Deferred Tax since Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Processa Pharmaceuticals 4.81 Mn -8.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -135.00
Dec 31, 2015 -16,533.00
Dec 31, 2014 155,232.00
API Access

Processa Pharmaceuticals Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=PCSA&period=max&api_key=YOUR_API_KEY